Endometrial compaction (decreased thickness) in response to progesterone results in optimal pregnancy outcome in frozen-thawed embryo transfers.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
09 2019
Historique:
received: 09 12 2018
revised: 30 04 2019
accepted: 01 05 2019
pubmed: 30 6 2019
medline: 14 5 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

To evaluate whether the change in endometrial thickness between the end of the estrogen phase and the day of embryo transfer has an impact on the pregnancy rate in frozen-thawed embryo transfer (FET) cycles. Retrospective observational cohort study. Single tertiary care medical center. Ultrasound images in 274 FET cycles were reviewed. All patients underwent endometrial preparation with the use of hormonal therapy. Ultrasound measurements of endometrial thickness at the end of the estrogen phase and the day of embryo transfer. The change in endometrial thickness and ongoing pregnancy rate. We calculated the ongoing pregnancy rate in patients whose endometrial thickness decreased (compacted) after starting progesterone by 5%, 10%, 15%, or 20% compared with patients with no change or increased endometrial thickness. The ongoing pregnancy rate was significantly increased at all levels of compaction compared with no compaction. The ongoing pregnancy rate showed a significant increase with each decreasing quartile of change in thickness (increased percentage of compaction) in the progesterone phase compared with the estrogen phase. There is a highly significant inverse correlation between the ongoing pregnancy rate and the change of endometrial thickness between the end of estrogen administration and the day of embryo transfer.

Identifiants

pubmed: 31248618
pii: S0015-0282(19)30425-X
doi: 10.1016/j.fertnstert.2019.05.001
pii:
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

503-509.e1

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Jigal Haas (J)

TRIO Fertility, Toronto, Ontario, Canada; IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ramsey Smith (R)

TRIO Fertility, Toronto, Ontario, Canada.

Eran Zilberberg (E)

TRIO Fertility, Toronto, Ontario, Canada.

Dan Nayot (D)

TRIO Fertility, Toronto, Ontario, Canada.

James Meriano (J)

TRIO Fertility, Toronto, Ontario, Canada.

Eran Barzilay (E)

IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Robert F Casper (RF)

TRIO Fertility, Toronto, Ontario, Canada; Department of Obstetrics and Gynecology, University of Toronto, and Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada. Electronic address: casper@lunenfeld.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH